FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068175717> ?p ?o ?g. }

• W2068175717 endingPage "374" @default.
• W2068175717 startingPage "367" @default.
• W2068175717 abstract "Implementation of a generalized screening program for neonatal diseases obeys precise guidelines. The disease must be severe, recognizable at an early stage, accessible to an effective treatment, detected with a non expansive and widely applicable test and it must represent an important health problem. In case of positive results, treatment or prevention shall be offered immediately and any screening program has to be regularly evaluated. There is in France since 1978 a national screening program that depends on a private association (Association française pour le dépistage et la prévention des handicaps de l'enfant) and is supervised by the Caisse nationale d'assurance maladie and the Direction Générale de la Sante. Presently, five diseases are included in the screening program: phenylketonuria, hypothyroidism, congenital adrenal hyperplasia, cystic fibrosis and sickle cell disease, the latter only in at risk newborns. Toxoplasmosis represents a particular problem because screening takes place only in children of mothers that have not been controlled during their pregnancy or in case of seroconversion. Neonatal screening of phenylketonuria and hypothyrodism is unanimously recommended. That of congenital adrenal hyperplasia is approved in most countries. The cases of sickle cell disease and cystic fibrosis are more complex because: 1) all the children that carry the mutations are not affected with a severe disease; 2) there is no curative treatment; 3) parents given information are made anxious, sometimes wrongly if the disease is mild or asymptomatic. The supporters of the screening insist on the interest of an early diagnosis which makes longer the life time of these children, the possibility for the parents to utilize prenatal screening in case of a future pregnancy, and the information given to the heterozygous carriers following a familial screening. The question is raised of the extension of neonatal screening to other diseases. This is now possible due to technical progresses such as the tandem mass spectrometry that can detect about 50 diseases in an only testing. In addition of its cost and of the difficulty to ensure an efficient organization, increasing the number of the screened diseases will raise ethical problems including how the parents will be informed of an incurable disease or a late-onset disease or an entirely asymptomatic disease. It is unanimously admitted that only mendelian diseases should be detected excluding genetic polymorphisms. Analysis of the present situation suggests the following developments: 1) to actualize the guidelines for deciding of a new neonatal screening; 2) to experiment on a local scale any new screening before its extension to the whole country; 3) to create an evaluation committee including paediatricians and epidemiologists and to evaluate on the long term the future of the children; 4) to precisely define the conditions in which the heterozygous carriers will be informed following a familial investigation; 5) to store in a resource biological centre the blood samples in order to utilize this bank for epidemiology studies." @default.
• W2068175717 created "2016-06-24" @default.
• W2068175717 creator A5020116197 @default.
• W2068175717 creator A5025480055 @default.
• W2068175717 date "2007-04-01" @default.
• W2068175717 modified "2023-09-27" @default.
• W2068175717 title "Le dépistage néonatal généralisé par des tests d'analyse biologique" @default.
• W2068175717 cites W1490540373 @default.
• W2068175717 cites W1549090036 @default.
• W2068175717 cites W1700762969 @default.
• W2068175717 cites W1719277316 @default.
• W2068175717 cites W2003927473 @default.
• W2068175717 cites W2004235323 @default.
• W2068175717 cites W2027235588 @default.
• W2068175717 cites W2028786000 @default.
• W2068175717 cites W2035416331 @default.
• W2068175717 cites W2062514603 @default.
• W2068175717 cites W2088993157 @default.
• W2068175717 cites W2090311410 @default.
• W2068175717 cites W2092850252 @default.
• W2068175717 cites W2125500266 @default.
• W2068175717 cites W2134254011 @default.
• W2068175717 cites W2147995261 @default.
• W2068175717 cites W2171955036 @default.
• W2068175717 cites W2231550469 @default.
• W2068175717 cites W2315871011 @default.
• W2068175717 cites W2327619328 @default.
• W2068175717 cites W2521050621 @default.
• W2068175717 cites W3020150929 @default.
• W2068175717 cites W4210400066 @default.
• W2068175717 cites W56095902 @default.
• W2068175717 cites W2913693499 @default.
• W2068175717 doi "https://doi.org/10.1016/j.gyobfe.2007.02.008" @default.
• W2068175717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17400505" @default.
• W2068175717 hasPublicationYear "2007" @default.
• W2068175717 type Work @default.
• W2068175717 sameAs 2068175717 @default.
• W2068175717 citedByCount "3" @default.
• W2068175717 countsByYear W20681757172014 @default.
• W2068175717 countsByYear W20681757172015 @default.
• W2068175717 crossrefType "journal-article" @default.
• W2068175717 hasAuthorship W2068175717A5020116197 @default.
• W2068175717 hasAuthorship W2068175717A5025480055 @default.
• W2068175717 hasConcept C126322002 @default.
• W2068175717 hasConcept C187212893 @default.
• W2068175717 hasConcept C2776169613 @default.
• W2068175717 hasConcept C2776938444 @default.
• W2068175717 hasConcept C2777767042 @default.
• W2068175717 hasConcept C2777910003 @default.
• W2068175717 hasConcept C2779134260 @default.
• W2068175717 hasConcept C2779258352 @default.
• W2068175717 hasConcept C29456083 @default.
• W2068175717 hasConcept C3020067899 @default.
• W2068175717 hasConcept C526584372 @default.
• W2068175717 hasConcept C71924100 @default.
• W2068175717 hasConceptScore W2068175717C126322002 @default.
• W2068175717 hasConceptScore W2068175717C187212893 @default.
• W2068175717 hasConceptScore W2068175717C2776169613 @default.
• W2068175717 hasConceptScore W2068175717C2776938444 @default.
• W2068175717 hasConceptScore W2068175717C2777767042 @default.
• W2068175717 hasConceptScore W2068175717C2777910003 @default.
• W2068175717 hasConceptScore W2068175717C2779134260 @default.
• W2068175717 hasConceptScore W2068175717C2779258352 @default.
• W2068175717 hasConceptScore W2068175717C29456083 @default.
• W2068175717 hasConceptScore W2068175717C3020067899 @default.
• W2068175717 hasConceptScore W2068175717C526584372 @default.
• W2068175717 hasConceptScore W2068175717C71924100 @default.
• W2068175717 hasIssue "4" @default.
• W2068175717 hasLocation W20681757171 @default.
• W2068175717 hasLocation W20681757172 @default.
• W2068175717 hasOpenAccess W2068175717 @default.
• W2068175717 hasPrimaryLocation W20681757171 @default.
• W2068175717 hasRelatedWork W2366779353 @default.
• W2068175717 hasRelatedWork W2403254519 @default.
• W2068175717 hasRelatedWork W2416276657 @default.
• W2068175717 hasRelatedWork W2789437060 @default.
• W2068175717 hasRelatedWork W3093153487 @default.
• W2068175717 hasRelatedWork W4210591379 @default.
• W2068175717 hasRelatedWork W4306679728 @default.
• W2068175717 hasRelatedWork W79315717 @default.
• W2068175717 hasRelatedWork W85945894 @default.
• W2068175717 hasRelatedWork W1792818044 @default.
• W2068175717 hasVolume "35" @default.
• W2068175717 isParatext "false" @default.
• W2068175717 isRetracted "false" @default.
• W2068175717 magId "2068175717" @default.
• W2068175717 workType "article" @default.